"Since last April, 19 cancer patients whose liver tumors hadn’t responded to chemotherapy have taken an experimental drug. Within weeks of the first dose, it appeared to work, by preventing tumors from making proteins they need to survive. The results are preliminary yet encouraging. With a slight redesign, the drug might work for hundreds of diseases, fulfilling the promise that wonder cures like stem cells and gene therapy have failed to deliver."
Choking a Tumor MRI scans show that blood flow [red] decreases in liver tumors after ALN-VSP therapy, which stops cancer cells from making proteins that form blood vessels. Courtesy ALNYLAM
[Popular Science]
No comments:
Post a Comment